Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 745–768 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Diabetes Mellitus, Type 2
Interventions: Orforglipron, Dulaglutide; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 10 Years to 17 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 17
States / cities: Sacramento, California • San Diego, California • Stamford, Connecticut + 14 more

Conditions: Voice Disorders
Interventions: Microlaryngoscopy, Voice Evaluation, Airway Reconstruction; Procedure
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Years to 30 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pregnancy Prevention, Life Skill Development
Interventions: Healthy Adolescent Transitions (HAT) program; Behavioral
Lead sponsor: Jack Stevens; Other
Eligibility: 14 Years to 19 Years · Female only
Enrollment: 331 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Chronic Rhinosinusitis (CRS), Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Interventions: OCEAN, Steroid-eluting sinus stent; Device
Lead sponsor: Polyganics BV; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 9
States / cities: Colorado Springs, Colorado • Atlanta, Georgia • Chicago, Illinois + 6 more

Conditions: Management of Anticoagulation
Interventions: INRatio monitor by Hemosense, Usual Care; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Clostridium Difficile, Clostridium Infections
Interventions: SYN-004, Placebo; Drug
Lead sponsor: Theriva Biologics, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 413 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 6
States / cities: Little Rock, Arkansas • Torrance, California • DeLand, Florida + 3 more

Conditions: Aphasia
Interventions: Simultaneous music and reading lyrics, Priming with music, Control; Behavioral
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Rocky Mount, Virginia

Conditions: Coagulopathy, Hemorrhage
Interventions: Autologous Spray Dried Plasma; Combination Product
Lead sponsor: Velico Medical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Cincinnati, Ohio • Milwaukee, Wisconsin • West Bend, Wisconsin

Conditions: Parkinson Disease
Interventions: Gait tests with and without the use of a tactile sensory cue (electrical stimulation using a TENS unit); Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 50 Years to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cannabis Use, Delinquency
Interventions: Brief Family Based Intervention, Parenting Psychoeducation; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 12 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Interstitial Lung Disease
Interventions: ILD, Healthy, Pneumonia; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 635 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Sleep Apnea, Obstructive
Interventions: Coblation (radiofrequency-based device); Device
Lead sponsor: ArthroCare Corporation; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Schizophrenia
Interventions: Org 24448, Placebo; Drug · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 8
States / cities: Los Angeles, California • Catonsville, Maryland • Boston, Massachusetts + 4 more

Conditions: Immune Thrombocytopenia, Chemotherapy Induced Thrombocytopenia, Myelodysplasia, Aplastic Anaemia
Interventions: Immune Thrombocytopenics, Hypo-proliferative thrombocytopenics, Control Population; Other
Lead sponsor: Beth Israel Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Suction Catheter Bioburder Level After Patient Use.
Interventions: Not listed
Lead sponsor: Egret Medical Products Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Spinal Procedure Requiring Dura Incision
Interventions: Spinal Sealant System, Standard of care; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Bedford, Massachusetts

Conditions: Chronic Low Back Pain
Interventions: Extended release hydrocodone and acetaminophen (Vicodin CR), hydrocodone/acetaminophen extended release (Vicodin CR), placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 770 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 63
States / cities: Hueytown, Alabama • Phoenix, Arizona • Tempe, Arizona + 52 more

Conditions: Obesity, Childhood
Interventions: Pilot Intervention to reduce SSB consumption in children and families enrolled in WIC; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 6 Months to 4 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Ventilation
Interventions: Spontaneous ventilation, Pressure support ventilation, Pressure control ventilation; Other · Device
Lead sponsor: Wake Forest University; Other
Eligibility: 1 Month to 11 Months
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Major Depressive Disorder \(MDD, Depressive Disorder, Major
Interventions: Active VeNS Device, Sham VeNS Device; Device
Lead sponsor: Neurovalens Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Pterygium
Interventions: CBT-001, Vehicle; Drug
Lead sponsor: Cloudbreak Therapeutics, LLC; Industry
Eligibility: 12 Years and older
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 20
States / cities: Dothan, Alabama • Sun City, Arizona • Bakersfield, California + 16 more

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: EXPD-101/FXS7553 Dose 1, EXPD-101/FXS7553 Dose 2, Placebo; Drug
Lead sponsor: Expedition Therapeutics, Inc; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 29
States / cities: Phoenix, Arizona • Encino, California • Northridge, California + 26 more

Conditions: Multiple Myeloma
Interventions: Velcade, Melphalan, Prednisone, Daratumumab IV, Dexamethasone, Daratumumab SC; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 706 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 10
States / cities: California City, California • Corona, California • Fountain Valley, California + 7 more

Conditions: Hernia
Interventions: mesh reinforcement of stoma, no intervention; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction

Healthy Adolescent Transitions (HAT)

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)

Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care

A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

Effect of Music on Reading Comprehension in Patients With Aphasia

Ascending Dose Study of FrontlineODP™ Spray Dried Plasma

The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease

Brief Family-Based Cannabis Use Intervention for Youth With Early Juvenile Justice Involvement

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

Study to Evaluate Recovery From Postoperative Pain After Sleep Apnea Surgery

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Study the Average Aerobic Bioburden Levels on Catheters After Use With Egret Catheter and the Predicate Device

Study to Evaluate Safety and Effectiveness of Spinal Sealant

A Study of Pain Relief in Low Back Pain

Expanding Health System Intervention Through The Women, Infants and Children (WIC) Program Partnership

A Comparison of Different Ventilation Strategies in Infants Using the PLMA™

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation